Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of BW-201 (Adj 1) RSV vaccine in adults aged 60 years and older
CTR20262838Phase 3Active
- Sponsor
- Baiyi Wuyou
- Start
- Jul 2026
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of BW-201 in respiratory syncytial virus disease (RSV), sponsored by Baiyi Wuyou. Started Jul 2026; status: active.
02
Drugs
BW-201
03
Conditions
respiratory syncytial virus disease (RSV)
Beyond the preview
Go deeper on CTR20262838.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20262838.